期刊文献+

米非司酮对雄激素非依赖性前列腺癌LNCaPC_(4-2)和PC3细胞的作用机制 被引量:2

Inhibiting Mechanism of Mifepristone on Androgen-Independent Prostate Cancer Cell Lines LNCaPC_(4-2) ,PC3 in Vitro
下载PDF
导出
摘要 为探讨抗孕激素药米非司酮对雄激素非依赖性前列腺癌细胞株LNCaPC4 2 、PC3的促凋亡及生长抑制作用 ,将不同浓度的米非司酮加入到体外培养的 2株前列腺癌细胞中 ,分别在培养后 3d、5d、7d用SRB染色法检测细胞生长抑制率 ;用流式细胞仪检测加药后 2 4h、48hLNCaPC4 2 和PC3细胞凋亡情况。发现 :高浓度米非司酮 ( 2 0μmol/L)对雄激素非依赖性细胞株LNCaPC4 2 、PC3于 3d、5d、7d的细胞生长抑制率分别为 5 5 .79%、66.3 7%、71 .5 4%和 87.42 %、98.1 5 %、1 0 0 %。不同浓度米非司酮即 2 .5、5、1 0、1 5、2 0 μmol/L对LNCaPC4 2 、PC3细胞株 7d时的细胞生长抑制率分别为 1 7.0 7%、3 5 .77%、5 3 .66%、63 .41 %、71 .5 4%和 48.2 5 %、63 .42 %、82 .3 7%、95 .3 1 %、1 0 0 %。前列腺癌细胞株LNCaPC4 2 受 1 5 μmol/L米非司酮作用 2 4h和 48h细胞凋亡率分别为 1 9.3 0 %、3 0 .0 4% ;PC3受米非司酮 1 5 μmol/L作用 2 4h细胞凋亡率为 44.5 2 %。提示 :米非司酮对LNCaPC4 2 、PC3细胞株有时间和剂量依赖的生长抑制作用 ,其生长抑制作用是通过促进细胞凋亡实现的。 The aim was to present our attempts on investigating the pro-apoptosis and growth suppression effects of antiprogestin mifepristone on androgen-independent prostate cancer cell lines LNCaPC 4-2 , PC3 in vitro. Using SRB method, the inhibition rates of different concentrations of mifepristone on the two cell lines were studied after drug 3 d, 5 d and 7 d after administration. The study also assessed the apoptosis rates induced by 15 μmol/L mifepristone on LNCaPC 4-2 , PC3 cell lines after 24 h, 48 h treatment. When the LNCaPC 4-2 cell line and the PC3 cell line were treated with 20 μmol/L mifepristone, the corresponding rates were 55.79%, 66.37%, 71.54% and 87.42%, 98.15 %, 100% on the 3 rd day, 5 th day and 7 th day. When the two cell lines were dealt with different concentrations of mifepristone 2.5 μmol/L, 5 μmol/L, 10 μmol/L, 15 μmol/L, 20 μmol/L, the corresponding suppression rates on the 7 th day were: 17.07%, 35.77%, 53.66%, 63.41%, 71.54 % and 48.25%, 63.42%, 82.37%, 95.31 %, 100% respectively. Using flow cytometry method, the apoptosis rates of 15 μmol/L mifepristone for LNCaPC 4-2 cell line were: 19.30% at 24 h and 30.04 % at 48 h, for PC3 cell line was 44.52% at 24 h. Antiprogestin mifepristone can induce apoptosis of androgen-independent prostate cancer cell lines LNCaPC 4-2 , PC3 in vitro. This pro-apoptosis effect is time-and-dose dependent.
出处 《首都医科大学学报》 CAS 2004年第2期250-252,共3页 Journal of Capital Medical University
关键词 米非司酮 雄激素非依赖性 前列腺癌 细胞株 凋亡 mifepristone androgen-independent prostate cancer cell line apoptosis
  • 相关文献

参考文献4

  • 1Ragha D, Koczwara B. Evolving strategies of cytotoxic chemotherapy for advanced prostate cancer. E ur J Cancer, 1997,33:566~574
  • 2Kuban D A, Shelhammer P F. Hemibody irradiation in advance d prostatic carcinoma. Urology Clin North Am, 1991,18(1):131~137
  • 3El Etraby M F, Yayun Liang. Induction of apoptosis by mife pristone and tamoxifen in human LNCaP prostate cancer cell culture. Prostate, 20 00,43:31~42
  • 4Lewis R W, Lewis J E. A preoperative plot clinical trial to study the effects of the antiprogestin,mifepristone in patients with op erable prostate cancer. Prostate, 1999,42:37~56

同被引文献35

  • 1Harada K, Kubo H,Abe J,et al. Discovery of potent and orally bioavailable 1713-hydroxysteroid dehydrogenase type 3 inhibitors J I. Bioorg Med Chem, 2012,20 (10) : 3242-3254.
  • 2Ebeling P, Koivisto VA. Physiological importance of dehydroepiandros- terone[ J ]. Lancet, 1994,343 ( 8911 ) : 1479-1481.
  • 3Adams JB. Control of secretion and the function of C19-delta 5- steroids of the human adrenal gland [J]. Mol Cell Endoerinol, 1985, 41 (1):1-17.
  • 4Mindnich R, Moller G, Adamski J. The role of 17 beta-hydroxysteroid dehydrogenases[ J ]. Mol Cell Endocrinol, 2004,218 ( 1-2 ) : 7-20.
  • 5Adamski J,Jakob FJ. A guide to 17beta-hydroxysteroid dehydroge- nases[ J ]. Mol Cell Endocrinol, 2001,171 ( 1-2): 1-4.
  • 6Mindnich R,Hrabe de Angelis M,Adamski J. Functional genome analysis indicates loss of 17beta-hydroxysteroid dehydrogenase type 2 enzyme in the zebrafish[J]. J Steroid Biochem ]Viol Biol,2007,103 ( 1 ) : 35-43.
  • 7Spires TE, Fink BE, Kick EK, et al. Identification of novel functional inhibitors of 17 beta-hydroxysteroid dehydrogenase type ( 17beta- HSD3 ) [J]. Prostate, 2005,65 (2) : 159-170.
  • 8Seher HI, Buchanan G, Gerald W, et al. Targeting the androgen re- ceptor:improving outcomes for castration-resistant prostate cancer [J]. Endocr Relat Cancer,2004,11 (3):459-476.
  • 9Roach M. Hormonal therapy and radiotherapy for localized prostate cancer:who,where and how long?[J]. J Uml,2003,170 (6 Pt 2): S35-S40.
  • 10Kruehten P,Werth R,Bey E,et al. Selective inhibition of 17beta- hydroxysteroid dehydrogenase type 1 (17betaHSD1) reduces estro- gen responsive cell growth of T47-D breast cancer cells[ J ]. J Steroid Biochem Mol Biol, 2009,114 (3-5) : 200-206.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部